AnalYTE SENSORS AND METHODS OF USE THEREOF
Summary
The USPTO published Abbott Diabetes Care Inc.'s patent application (US20260090745A1) for analyte sensors capable of detecting biological analytes using multiple enzyme systems. Inventors Zenghe Liu and Benjamin J. Feldman developed the disclosed technology for medical diagnostic applications.
What changed
This document represents the publication of a new patent application (A1 publication) by Abbott Diabetes Care Inc. for analyte sensors featuring two or more enzyme systems to detect various biological analytes. The application covers both the sensor apparatus and associated detection methods.
This is an informational publication only and does not create any new compliance obligations or regulatory requirements. Medical device manufacturers and pharmaceutical companies developing similar sensor technologies should review the patent claims for competitive intelligence and potential licensing considerations. Patent applications do not impose immediate regulatory compliance deadlines or penalties.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANALYTE SENSORS AND METHODS OF USE THEREOF
Application US20260090745A1 Kind: A1 Apr 02, 2026
Assignee
ABBOTT DIABETES CARE INC.
Inventors
Zenghe Liu, Benjamin J. Feldman
Abstract
The present disclosure provides an analyte sensor for use in detecting various analytes. In certain embodiments, an analyte-responsive active area of a presently disclosed analyte sensor includes two or more enzyme systems for detecting the analyte. The present disclosure further provides methods for detecting various analytes using the disclosed analyte sensors.
CPC Classifications
A61B 5/14865 A61B 5/14532 C12N 9/0006 C12Y 101/01008
Filing Date
2025-10-22
Application No.
19365839
Related changes
Get daily alerts for ChangeBridge: Patent Apps - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Diagnosis & Surgery (A61B) publishes new changes.